Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review

Objective. To evaluate ginsenoside Rg3 combined with chemotherapy for non-small-cell lung cancer (NSCLC) treatment, in a meta-analysis. Materials and Methods. We searched PubMed, EMBASE, the Cochrane Library, the China National Knowledge Infrastructure, and the VIP and Wanfang databases for eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tao, Jin, Zhichao, Yuan, Yuan, Wei, Huamin, Xu, Xinyao, He, Shulin, Chen, Shuntai, Hou, Wei, Guo, Qiujun, Hua, Baojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069366/
https://www.ncbi.nlm.nih.gov/pubmed/27800005
http://dx.doi.org/10.1155/2016/7826753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069366/
https://www.ncbi.nlm.nih.gov/pubmed/27800005
http://dx.doi.org/10.1155/2016/7826753

Ejemplares similares